Dr. Andrew J. Phillips, is a Director of MoonLake. He is President and Chief Executive Officer of Alekisa Therapeutics and Blossom Bioscience Ltd.  He was previously Managing Director at Cormorant Asset Management and also served as Chief Financial Officer of Helix Acquisition Corp.  He is a Director at other private companies.   In 2016-2020, he was with C4 Therapeutics, Inc. as Chief Scientific Officer from 2016-2018 and as President and Chief Executive Officer from 2018-2020. In 2014-2016, he served as Senior Director, Center for Development of Therapeutics at the Broad Institute.  From 2010 to 2015, Dr. Phillips was a Professor of Chemistry at Yale University, and from 2001 to 2010 he held Professorship positions at the University of Colorado. He holds a B.Sc. in Biochemistry and a Ph.D. in Chemistry from the University of Canterbury in New Zealand.